Global Health News and Research

RSS

More men contract chlamydia in Australia, finds new study

The largest Australian chlamydia study to date, led by the University of Melbourne, has found more men contract chlamydia than previously thought and most cases of infection are being missed.

17 Feb 2014

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

A grandfather-of-three from Tameside is helping University of Manchester researchers become the first in the world to assess all the genetic links with Chronic Pulmonary Aspergillosis (CPA) - a debilitating fungal lung infection that claims the lives of thousands of people in the UK and millions more worldwide.

From The University of Manchester 12 Feb 2014

Dental care in schools for children wipes out social inequities

A new survey conducted by the University of Copenhagen and the World Health Organization (WHO) is highlighting the role of schools in work to promote health and prevent disease.

11 Feb 2014

Researchers shed new light on pain associated with bacterial infections

Components in the outer wall of bacteria directly activate pain sensors, triggering immediate pain and inflammatory responses. This finding by a multinational team of researchers led by Professor Karel Talavera (KU Leuven, Belgium) and Professor Félix Viana (Institute of Neuroscience, Spain) sheds new light on pain associated with bacterial infections and reveals a new target for drugs designed to treat them.

11 Feb 2014

Allianz Worldwide Care introduces Maritime Healthcare Plan for seafarers

Global health insurer Allianz Worldwide Care has announced the launch of a new plan which offers a compliant solution for onshore healthcare to shipping companies affected by the Maritime Labour Convention 2006 (MLC 2006), commonly known as the "Seafarers' Bill of Rights". MLC 2006, which came into force in August 2013, requires shipping companies to provide comprehensive rights and protection to the world's 1.2 million seafarers, including the provision of a minimum level of healthcare cover.

10 Feb 2014

New study tracks spread of H5N1 variant in Egypt recently identified as major epicenter for virus

Since its first identification in Asia, highly pathogenic avian influenza-H5N1-has caused significant alarm in the scientific community. While the virus' primary target is birds-tens of millions have already died from it-it is capable of infecting mammals, including humans, causing serious illness and a frightening rate of mortality.

10 Feb 2014

Despite jump in enrollment, Aetna says it faces losses from health law marketplaces

Aetna Inc. said it expects to lose money on its business in the health-law marketplaces this year, with the demographics of enrollees skewing slightly more than expected toward people likely to rack up higher costs. The insurer, which is participating in public consumer exchanges in 16 states and the District of Columbia, the most of any carrier, said it has signed up about 135,000 paid members through the end of January (Mathews, 2/6).

9 Feb 2014

First Edition: February 7, 2014

Today's headlines include reports from Capitol Hill about the continuing efforts to overhaul Medicare's payment system for doctors.

9 Feb 2014

Rice, UTMB develop diagnostic test for cryptosporidiosis

Bioengineers at Rice University and the University of Texas Medical Branch (UTMB) at Galveston have developed a simple, highly sensitive and efficient test for the diarrheal disease cryptosporidiosis that could have great impact on global health.

7 Feb 2014

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.

5 Feb 2014

Population Council launches large new research program to benefit adolescent girls in Kenya

The Population Council announced today the launch of a large new research program designed to benefit adolescent girls in Kenya. The initiative will provide girls with access to interventions in the health, wealth creation, education, and violence-prevention sectors.

5 Feb 2014

Sanford Hospital starts clinical trial to study dissolving device in patients with CAD

Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.

4 Feb 2014

Addressing antibiotic resistance: an interview with Professor Otto Cars, Uppsala University, Sweden

Antibiotic resistance is a consequence of antibiotic use. Bacteria adapt to the threat of antibiotics using mechanisms to overcome the drug. These bacteria, which we call resistant bacteria, then survive.

3 Feb 2014

Keystone Symposia to convene conference focusing on the science of malaria eradication

Keystone Symposia, in collaboration with MESA (Malaria Eradication Scientific Alliance), is convening its first conference in Mexico – on "The Science of Malaria Eradication" at the Fiesta Americana Hotel in Merida, Yucatan. The four-day conference begins Sunday evening, February 2, 2014 and is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, which has also funded travel awards for investigators from malaria-endemic countries to attend. The conference will gather experts from 37 countries.

31 Jan 2014

Bubble CPAP device increases survival rate of newborns with severe respiratory illness

The first clinical study of a low-cost neonatal breathing system created by Rice University bioengineering students demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent.

31 Jan 2014

NIBIO signs collaboration agreement for clinical development of new mucosal TB vaccines

Japan's National Institute of Biomedical Innovation ("NIBIO"), Aeras and Create Vaccine Company, Ltd ("CREATE") announce today that they signed a collaboration agreement on December 26, 2013, on the preclinical and clinical development of new mucosal tuberculosis (TB) vaccines based on NIBIO's human parainfluenza type-2 (rhPIV2) vector technology.

27 Jan 2014

Global Health News and Research

More men contract chlamydia in Australia, finds new study

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

Dental care in schools for children wipes out social inequities

Researchers shed new light on pain associated with bacterial infections

Allianz Worldwide Care introduces Maritime Healthcare Plan for seafarers

New study tracks spread of H5N1 variant in Egypt recently identified as major epicenter for virus

Despite jump in enrollment, Aetna says it faces losses from health law marketplaces

First Edition: February 7, 2014

Rice, UTMB develop diagnostic test for cryptosporidiosis

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Population Council launches large new research program to benefit adolescent girls in Kenya

Sanford Hospital starts clinical trial to study dissolving device in patients with CAD

Addressing antibiotic resistance: an interview with Professor Otto Cars, Uppsala University, Sweden

Keystone Symposia to convene conference focusing on the science of malaria eradication

Bubble CPAP device increases survival rate of newborns with severe respiratory illness

NIBIO signs collaboration agreement for clinical development of new mucosal TB vaccines

Copenhagen researchers boost self-efficacy of diabetic patients through motivational health coaching

USF Health receives $2.1M grant to study on new factors required for growth of malaria-related parasites

Scientists to decode intestinal disease bacteria using genome sequencing technologies

The fight against HIV/AIDS: an interview with Dr. Mit Philips, HIV/AIDS Policy Analyst, Médecins Sans Frontières (MSF)

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News